Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Abbott
The settlements resolve False Claims Act allegations against St. Jude and Alere, as well as misbranding allegations against Avanos Medical.
The two suits address a total of 17 patents on elements of continuous glucose monitors, or CGMs.
The US FDA has affixed its highest risk classification to Abbott’s recall of 61,973 of the implantable devices. The pacemakers can short-circuit if moisture gets inside.
Following a €2.5m award from the European Commission’s EIC Accelerator Program, Paris based CorWave has become the first EU company to obtain EIC fund investment. The company is developing a new pulsatile LVAD.
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
- Other Names / Subsidiaries
- Medscreen Ltd.